Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications.

Morfouace M, Lalier L, Bahut M, Bonnamain V, Naveilhan P, Guette C, Oliver L, Gueguen N, Reynier P, Vallette FM.

J Biol Chem. 2012 Sep 28;287(40):33664-74.

2.

Control of glioma cell death and differentiation by PKM2-Oct4 interaction.

Morfouace M, Lalier L, Oliver L, Cheray M, Pecqueur C, Cartron PF, Vallette FM.

Cell Death Dis. 2014 Jan 30;5:e1036. doi: 10.1038/cddis.2013.561.

3.
4.

Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.

Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.

Oncogene. 2000 Jul 20;19(31):3508-20. Erratum in: Oncogene. 2006 Nov 30;25(56):7440.

5.

Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.

Tagscherer KE, Fassl A, Campos B, Farhadi M, Kraemer A, Böck BC, Macher-Goeppinger S, Radlwimmer B, Wiestler OD, Herold-Mende C, Roth W.

Oncogene. 2008 Nov 6;27(52):6646-56. doi: 10.1038/onc.2008.259.

PMID:
18663354
6.
7.
8.

Metabolic modulation of glioblastoma with dichloroacetate.

Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC.

Sci Transl Med. 2010 May 12;2(31):31ra34. doi: 10.1126/scitranslmed.3000677.

9.

Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo.

Zwicker F, Kirsner A, Peschke P, Roeder F, Debus J, Huber PE, Weber KJ.

Strahlenther Onkol. 2013 Aug;189(8):684-92. doi: 10.1007/s00066-013-0354-x.

PMID:
23793865
10.

Hypoxia enhances antitumor activity of dichloroacetate.

Kolesnik DL, Pyaskovskaya ON, Boichuk IV, Solyanik GI.

Exp Oncol. 2014 Dec;36(4):231-5.

PMID:
25537215
11.

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W.

Cancer Res. 2001 Mar 15;61(6):2744-50.

12.

Dual-targeting of aberrant glucose metabolism in glioblastoma.

Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL.

J Exp Clin Cancer Res. 2015 Feb 5;34:14. doi: 10.1186/s13046-015-0130-0.

13.

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.

Dong Y, Han Q, Zou Y, Deng Z, Lu X, Wang X, Zhang W, Jin H, Su J, Jiang T, Ren H.

Mol Cell Biochem. 2012 Nov;370(1-2):89-102. doi: 10.1007/s11010-012-1401-0.

PMID:
22829019
14.

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.

Stockwin LH, Yu SX, Borgel S, Hancock C, Wolfe TL, Phillips LR, Hollingshead MG, Newton DL.

Int J Cancer. 2010 Dec 1;127(11):2510-9. doi: 10.1002/ijc.25499.

15.

RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.

Goidts V, Bageritz J, Puccio L, Nakata S, Zapatka M, Barbus S, Toedt G, Campos B, Korshunov A, Momma S, Van Schaftingen E, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B.

Oncogene. 2012 Jul 5;31(27):3235-43. doi: 10.1038/onc.2011.490.

PMID:
22056879
16.

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.

PLoS One. 2011;6(8):e24099. doi: 10.1371/journal.pone.0024099.

17.

Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.

Glaser T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M, Weller M.

Br J Cancer. 1999 May;80(5-6):756-65.

18.

D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.

El Sayed SM, Abou El-Magd RM, Shishido Y, Chung SP, Sakai T, Watanabe H, Kagami S, Fukui K.

Cancer Gene Ther. 2012 Jan;19(1):1-18. doi: 10.1038/cgt.2011.59.

PMID:
21921941
19.

[Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture].

Giliano NY, Bondarev GN, Konevega LV, Noskin LA, Zhurishkina EV, Alchinova IB.

Patol Fiziol Eksp Ter. 2014 Oct-Dec;(4):78-85. Russian.

PMID:
25980231
20.

Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.

Xie J, Wang BS, Yu DH, Lu Q, Ma J, Qi H, Fang C, Chen HZ.

Int J Oncol. 2011 Feb;38(2):409-17. doi: 10.3892/ijo.2010.851.

PMID:
21132264

Supplemental Content

Support Center